Correct Answer: B. Methionine
The conversion of norepinephrine (NE) to epinephrine (E) is catalyzed by the enzyme phenylethanolamine N-methyltransferase (PNMT), which is located in the adrenal medulla. This enzyme transfers a methyl group from S-adenosylmethionine (SAM) — the universal methyl donor in the body — to the amino group of norepinephrine, producing epinephrine. Methionine is the precursor amino acid that, after activation by methionine adenosyltransferase (MAT), becomes SAM. Without adequate methionine availability, SAM synthesis is impaired, leading to reduced epinephrine synthesis. This is a critical step in catecholamine metabolism: tyrosine → L-DOPA → dopamine → norepinephrine → epinephrine. While tyrosine is the starting substrate and phenylalanine is converted to tyrosine, neither directly provides the methyl group needed for the final methylation step. In Indian clinical practice, methionine deficiency (rare but seen in severe malnutrition or certain genetic disorders) can theoretically impair epinephrine production, though the clinical manifestation is usually overshadowed by broader metabolic dysfunction. The PNMT enzyme and SAM-dependent methylation are high-yield concepts in NEET PG biochemistry.
Why the other options are wrong
A. Tryptophan — Tryptophan is the precursor for serotonin and kynurenine pathway metabolites, not catecholamine synthesis. It has no role in norepinephrine-to-epinephrine conversion. NBE includes this as a distractor because tryptophan is an important amino acid in neurotransmitter synthesis, but students must distinguish between different neurotransmitter pathways. C. Phenylalanine — Phenylalanine is converted to tyrosine by phenylalanine hydroxylase, and tyrosine is the starting substrate for catecholamine synthesis. However, phenylalanine does not directly participate in the methylation reaction that converts NE to E. This is a common trap because phenylalanine is upstream in the pathway but not the methyl donor. D. Tyrosine — Tyrosine is the essential amino acid precursor for the entire catecholamine pathway (tyrosine → L-DOPA → dopamine → NE → E). However, tyrosine is not the methyl donor for the final step. Students often confuse 'necessary for the pathway' with 'necessary for this specific reaction.' The question specifically asks about NE-to-E conversion, not the entire pathway.
High-Yield Facts
- PNMT (phenylethanolamine N-methyltransferase) catalyzes the methylation of norepinephrine to epinephrine using SAM as the methyl donor.
- S-adenosylmethionine (SAM) is synthesized from methionine by methionine adenosyltransferase (MAT); SAM is the universal methyl donor in all cells.
- Methionine is an essential amino acid that must be obtained from dietary sources; it is the precursor for SAM synthesis.
- The catecholamine synthesis pathway is: tyrosine → L-DOPA → dopamine → norepinephrine → epinephrine (requires methionine/SAM).
- PNMT is located exclusively in the adrenal medulla, making epinephrine synthesis an adrenal-specific process; other tissues produce only dopamine and norepinephrine.
Mnemonics
SAM = Methionine's Active Form S-AdenosylMethionine comes from Methionine. When you see 'methylation reaction,' think SAM. When you see SAM, think methionine. Use this when any question asks about methyl donors or methylation in the body. Catecholamine Pathway: TDD-NE-E Tyrosine → Dopamine → Dopamine → Norepinephrine → Epinephrine. The last step (NE→E) is unique: it's the only methylation step, requiring methionine/SAM. Use this to remember that while tyrosine starts the pathway, methionine finishes it.
NBE Trap
NBE pairs tyrosine and phenylalanine with catecholamine synthesis to trap students who know these amino acids are upstream in the pathway but confuse 'necessary for the overall pathway' with 'necessary for the specific NE-to-E conversion step.' The question's specificity to the final methylation reaction is the key discriminator.
Clinical Pearl
In Indian patients with severe protein-calorie malnutrition or homocystinuria (rare genetic disorder affecting methionine metabolism), impaired SAM synthesis can theoretically reduce epinephrine production, contributing to hypotensive episodes during acute stress. However, the clinical presentation is usually dominated by broader catecholamine dysfunction rather than isolated epinephrine deficiency.
_Reference: Harper's Biochemistry Ch. 32 (Catecholamine Synthesis); KD Tripathi Pharmacology Ch. 8 (Sympathomimetic Amines)_